Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Matilainen

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Shoulder and Elbow Surgery|October 13, 2024
Proximal humeral fractures in Finland: regional differences in incidence and methods of treatmentIda A Roivas, Oskari K Leino, Kaisa K Lehtimäki, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 17, 2022
Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple SclerosisOlavi Misin, Markus Matilainen, Marjo Nylund, et al.
Multiple Sclerosis and Related Disorders|February 13, 2022
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patientsMaija Saraste, Markus Matilainen, Cecilia Rajda, et al.
Multiple Sclerosis and Related Disorders|December 22, 2020
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot studyMaija Saraste, Svetlana Bezukladova, Marcus Sucksdorff, et al.
Multiple Sclerosis and Related Disorders|February 8, 2021
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTIMaija Saraste, Svetlana Bezukladova, Markus Matilainen, et al.
Annals of Clinical and Translational Neurology|July 2, 2026
Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple SclerosisMarlene T Morch, Markus Matilainen, Giulia N Baldrighi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2018
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severityHeidi Högel, Eero Rissanen, Christian Barro, et al.
Parkinsonism & Related Disorders|July 22, 2023
Adenosine A<sub>2A</sub> receptor availability in cerebral gray and white matter of patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Archives of Orthopaedic and Trauma Surgery|January 17, 2017
Survival of uncemented cups from a single manufacturer implanted from 1985 to 2013: Finnish Arthroplasty Register dataAntton Palomäki, Lasse Lempainen, Markus Matilainen, et al.
Journal of Neuroinflammation|February 3, 2026
Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosisMarjo Nylund, Jussi Lehto, Markus Matilainen, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Shoulder and Elbow Surgery|October 13, 2024
Proximal humeral fractures in Finland: regional differences in incidence and methods of treatmentIda A Roivas, Oskari K Leino, Kaisa K Lehtimäki, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 17, 2022
Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple SclerosisOlavi Misin, Markus Matilainen, Marjo Nylund, et al.
Multiple Sclerosis and Related Disorders|February 13, 2022
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patientsMaija Saraste, Markus Matilainen, Cecilia Rajda, et al.
Multiple Sclerosis and Related Disorders|December 22, 2020
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot studyMaija Saraste, Svetlana Bezukladova, Marcus Sucksdorff, et al.
Multiple Sclerosis and Related Disorders|February 8, 2021
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTIMaija Saraste, Svetlana Bezukladova, Markus Matilainen, et al.
Annals of Clinical and Translational Neurology|July 2, 2026
Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple SclerosisMarlene T Morch, Markus Matilainen, Giulia N Baldrighi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 21, 2018
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severityHeidi Högel, Eero Rissanen, Christian Barro, et al.
Parkinsonism & Related Disorders|July 22, 2023
Adenosine A<sub>2A</sub> receptor availability in cerebral gray and white matter of patients with Parkinson's diseaseImran Waggan, Eero Rissanen, Jouni Tuisku, et al.
Archives of Orthopaedic and Trauma Surgery|January 17, 2017
Survival of uncemented cups from a single manufacturer implanted from 1985 to 2013: Finnish Arthroplasty Register dataAntton Palomäki, Lasse Lempainen, Markus Matilainen, et al.
Journal of Neuroinflammation|February 3, 2026
Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosisMarjo Nylund, Jussi Lehto, Markus Matilainen, et al.
Pageof 6